Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2008 (Vol. 28, No. 19)

Genentech BioOncology Cancer Therapy Research

  • Nice hierarchical design
  • None
Everyone has heard of Genentech, but many researchers may not be aware of the company’s BioOncology site. With a focus on highlighting the company’s products targeting angiogenesis, apoptosis, signaling, development, and immunology, the BioOncology site has a lot of ground to cover. Navigation of the attractively designed site is fun in places (check out the History of Innovation timeline), informative in others (see Clinical Trials), and commercial elsewhere (click on Products). For a commercial site, BioOncology is surprisingly free of ads and doesn’t get in your face as you navigate. Other features of the site include a segment devoted to careers with the company, a lot of attractive graphics paired with intelligently written technical descriptions, and an animation or two thrown in (though these were not particularly informative). Overall, BioOncology is a solid effort from a solid company, and you don’t have to fret about overly commercial content.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »